Company Name: PhaseRx, Inc.    

PhaseRx, Inc. is a preclinical biopharmaceutical company. The company is engaged in the development of intracellular enzyme replacement therapy designed to treat inherited enzyme deficiencies in the liver.

Ticker Symbol: PZRX (NASDAQ)

Company Website: http://phaserx.com

Social Media: Phaserx LinkedIn

Headquarters: Seattle, Washington